Roivant Sciences Ltd (ROIV)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.037% |
| Hold Price * : | $27.70 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Polen Capital Management | Sell 100.00% | 9,662 | 0.00 | |
| Q4 2025 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 9.06% | 206,220 | 0.16 | |
| ≡ | Viking Global Investors | Reduce 72.69% | 17,151,640 | 0.98 | |
| Q3 2025 | |||||
| ≡ | Viking Global Investors | Reduce 31.09% | 10,642,948 | 0.42 | |
| ≡ | David Einhorn - Greenlight Capital | Reduce 50.00% | 2,275,528 | 1.35 | |
| Q2 2025 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 16.36% | 890,110 | 0.43 | |
| ≡ | Viking Global Investors | Reduce 25.59% | 11,775,973 | 0.39 | |
| Q1 2025 | |||||
| ≡ | Viking Global Investors | Reduce 3.76% | 1,796,208 | 0.06 | |
| Q4 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 0.70% | 36,973 | 0.02 | |
| ≡ | Viking Global Investors | Reduce 11.63% | 6,289,106 | 0.24 | |
| Q3 2024 | |||||
| ≡ | Viking Global Investors | Reduce 21.77% | 15,056,780 | 0.63 | |
| Q2 2024 | |||||
| ≡ | Viking Global Investors | Reduce 0.31% | 213,115 | 0.01 | |
| Q4 2023 | |||||
| ≡ | Viking Global Investors | Reduce 5.54% | 4,065,340 | 0.17 | |
| Q3 2023 | |||||
| ≡ | Viking Global Investors | Reduce 2.40% | 1,804,399 | 0.09 | |
| Q2 2023 | |||||
| ≡ | Viking Global Investors | Reduce 14.73% | 13,000,000 | 0.54 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.